Skip to content
Z Zendikt
Editorial verdict · Who it’s wrong for

Who shouldn’t buy Veradigm (formerly Allscripts)?

A direct read on the buyers Veradigm (formerly Allscripts) is the wrong fit for — sourced from the same editorial team that ranked the full Healthcare EHR Software category.

Worst for

New EHR evaluations (Epic/athenahealth/eClinicalWorks better fits and substantially more stable vendors), or any buyer prioritizing vendor stability for multi-year EHR commitments.

For context: who it IS for

Existing Veradigm customers on legacy Allscripts/TouchWorks/Sunrise platforms staying due to switching cost.

Target size: 10–10,000 · Legacy Veradigm/Allscripts customers

Why we say this

Editorial pulled these weaknesses from Veradigm (formerly Allscripts)’s product card in our Top 10 Healthcare EHR Software for 2026:

  • ! Multiple accounting restatements 2023-2024
  • ! NASDAQ delisting September 2024
  • ! Active SEC investigations
  • ! Uncertain corporate trajectory
  • ! Customer support degraded
  • ! Many customers migrating away

If Veradigm (formerly Allscripts) is wrong for you, consider these instead

Same Healthcare EHR Software category, different best-fit buyer.

Related editorial

Last updated 2026-05-10. Editorial verdict based on the published Top 10 Healthcare EHR Software for 2026 ranking. Disagree? Tell us.